Skip to main content

J1302 HCPCS Level II Code: Injection, sutimlimab-jome, 10 mg

Medicare Coverage & Payment

  • CMS short descriptor: Inj, sutimlimab-jome, 10 mg
  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Drugs (pricing indicator 51)
  • BETOS: O1E — Other drugs
  • Last CMS action effective: October 1, 2022

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Code Overview

Injection, sutimlimab-jome, 10 mg is a HCPCS Level II code (J1302). CMS assigns coverage code C — Carrier judgment. Short description: Inj, sutimlimab-jome, 10 mg.

Summary composed by MedCoder from this code's official HCPCS Level II record. The tabular instructional notes themselves appear verbatim below.

Change history

  • 2022-10-01
    Added to the code set
    Injection, sutimlimab-jome, 10 mg

Drug products (NDC)

CMS ASP NDC-HCPCS Crosswalk · 2026 Q3

Medicare Part B payment limit (ASP + 6%): $19.64

55292-0820-01 — Enjaymo — Recordati Rare Diseases Inc. (size 22 × qty 1 (10 MG per billing unit))

80203-0347-01 — Enjaymo — Bioverativ Therapeutics Inc. (size 22 × qty 1 (10 MG per billing unit))

From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.

Contextual Map

Every relationship of J1302 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (20)

  • J1300 — Injection, eculizumab, 10 mg [Sibling]
  • J1301 — Injection, edaravone, 1 mg [Sibling]
  • J1303 — Injection, ravulizumab-cwvz, 10 mg [Sibling]
  • J1304 — Injection, tofersen, 1 mg [Sibling]
  • J1305 — Injection, evinacumab-dgnb, 5mg [Sibling]
  • J1306 — Injection, inclisiran, 1 mg [Sibling]
  • J1307 — Injection, crovalimab-akkz, 10 mg [Sibling]
  • J1308 — Injection, famotidine, 0.25 mg [Sibling]
  • and 12 more

Change history

  • 2022-10-01 — Added to the code set [Change history]

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J1302 in its code family, with their registry titles.

  • J1300 — Injection, eculizumab, 10 mg
  • J1301 — Injection, edaravone, 1 mg
  • J1303 — Injection, ravulizumab-cwvz, 10 mg
  • J1304 — Injection, tofersen, 1 mg
  • J1305 — Injection, evinacumab-dgnb, 5mg
  • J1306 — Injection, inclisiran, 1 mg
  • J1307 — Injection, crovalimab-akkz, 10 mg
  • J1308 — Injection, famotidine, 0.25 mg
  • J1320 — Injection, amitriptyline hcl, up to 20 mg
  • J1322 — Injection, elosulfase alfa, 1 mg